AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Method for culturing patient-derived cancer cells expedites treatment decisions for bladder cancer

Summary

Michael M. Shen, Ph.D.

Technology Benefits

Ability to establish a cell line from only a small tumor sampleHigh efficiency rate (89%) with rapid cell growth timeframeCell lines can remain in culture for an extended period of timeCell lines can be frozen for long-term storage and thawed at a later date with normal growthPatient-derived cell lines would be specific to each bladder cancer case for personalized therapyPatent information:Patent PendingTech Ventures Reference: IR CU14280

Technology Application

Modeling the efficacy of intravesical therapy agents to determine course of action in treating bladder cancer patientsUse for drug therapy development to treat bladder cancerUse for pathophysiology studies of bladder cancerModeling diseases related to unregulated cell growthCreation of a tissue library of cancerous tissue for research purposes (bladder cancer or otherwise)

Detailed Technology Description

Michael M. Shen, Ph.D.

Country/Region

USA

For more information, please click Here